For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260506:nRSF2445Da&default-theme=true
RNS Number : 2445D Forterra plc 06 May 2026
6(th) May 2026
Forterra plc
("Forterra" or the "Company")
Transaction in Own Shares
Forterra plc ("Forterra" or the "Company") announces that it has purchased the
following number of its ordinary shares of 1.0 pence each through Investec
Bank plc in the period from 27(th) April 2026 to 1(st) May 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
27 April 2026 XLON 159.8992 137,501 158.4000 160.8000
28 April 2026 XLON 158.5497 91,216 157.2000 160.0000
29 April 2026 XLON 158.3162 82,063 157.4000 159.8000
30 April 2026 XLON 157.6034 57,853 156.4000 158.6000
01 May 2026 XLON 157.5430 95,000 156.4000 158.0000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Market Abuse Regulation (EU) No 596/2014
(as it forms part of the law of the United Kingdom by virtue of the European
Union (Withdrawal) Act 2018, as implemented, retained, amended, extended,
re-enacted or otherwise given effect in the United Kingdom from 1 January 2021
and as amended or supplemented in the United Kingdom thereafter) a full
breakdown of the individual trades made by Investec Bank plc on behalf of the
Company as part of the Programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/2445D_1-2026-5-6.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2445D_1-2026-5-6.pdf)
END
Enquires
Forterra plc:
+44 (0) 1604 707 600
Ben Guyatt (CFO)
Frances Tock (Company Secretary)
Further information relating to the Company and its group can be found at
www.forterraplc.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSDZGGKLVLGVZG
Copyright 2019 Regulatory News Service, all rights reserved